,first author name,journal,year,species,gene or protein name,drug,mutation,degree of evidence,MIC,strain_ID,strain origin if available,notes,mutation_cerevisiae
0,Garcia-Effron,Antimicrobial Agents and Chemotherapy,2008,Saccharomyces cerevisiae,Fks1,Caspofungin,P647A,2.0,0.5 μg/mL,BY4742,Lab,"CLSI with YPD, The equivalent in Candida parapsilosis, Candida orthopsilosis, and
Candida metapsilosis is A660. The authors have the hypothesis that this amino acid is responsible for the low susceptibility to caspofungin, micafungin, and anidulafungin of those organism. In the paper it seems like there is a mixup between P647A and P649A for S. cerevisiae at several places.",P647A
1,Garcia-Effron,Antimicrobial Agents and Chemotherapy,2008,Saccharomyces cerevisiae,Fks1,Micafungin,P647A,2.0,0.5 μg/mL,BY4742,Lab,"CLSI with YPD, The equivalent in Candida parapsilosis, Candida orthopsilosis, and
Candida metapsilosis is A660. The authors have the hypothesis that this amino acid is responsible for the low susceptibility to caspofungin, micafungin, and anidulafungin of those organism. In the paper it seems like there is a mixup between P647A and P649A for S. cerevisiae at several places.",P647A
2,Garcia-Effron,Antimicrobial Agents and Chemotherapy,2008,Saccharomyces cerevisiae,Fks1,Anidulafungin,P647A,2.0,0.5 μg/mL,BY4742,Lab,"CLSI with YPD, The equivalent in Candida parapsilosis, Candida orthopsilosis, and
Candida metapsilosis is A660. The authors have the hypothesis that this amino acid is responsible for the low susceptibility to caspofungin, micafungin, and anidulafungin of those organism. In the paper it seems like there is a mixup between P647A and P649A for S. cerevisiae at several places.",P647A
89,Park,Antimicrobial Agents and Chemotherapy,2005,Candida albicans,Fks1,Caspofungin,S645P,1.0,2 μg/mL,Transformant 1,Lab,,S643P
90,Park,Antimicrobial Agents and Chemotherapy,2005,Candida albicans,Fks1,Caspofungin,S645P,1.0,2 μg/mL,Transformant 2,Lab,,S643P
91,Park,Antimicrobial Agents and Chemotherapy,2005,Candida albicans,Fks1,Caspofungin,S645P,1.0,2 μg/mL,Transformant 3,Lab,,S643P
92,Park,Antimicrobial Agents and Chemotherapy,2005,Candida albicans,Fks1,Caspofungin,S645P,1.0,2 μg/mL,Transformant 8,Lab,,S643P
93,Park,Antimicrobial Agents and Chemotherapy,2005,Candida albicans,Fks1,Caspofungin,S645P,1.0,4 μg/mL,pJAM11 in CAI4-R1,Lab,,S643P
313,Avramovska,Frontiers in Fungal Biology,2022,Candida albicans,Fks1,Caspofungin,F641C,4.0,Not determined,MH84 (2N) ,Evolved,Looked at FKS1 as candidate gene; MIC values potentially available in mat sup,F639C
315,Avramovska,Frontiers in Fungal Biology,2022,Candida albicans,Fks1,Caspofungin,S645F,4.0,Not determined,MH128 (4N),Evolved,Looked at FKS1 as candidate gene; MIC values potentially available in mat sup,S643F
316,Avramovska,Frontiers in Fungal Biology,2022,Candida albicans,Fks1,Caspofungin,S645Y,4.0,Not determined,MH128 (4N),Evolved,Looked at FKS1 as candidate gene; MIC values potentially available in mat sup,S643Y
317,Avramovska,Frontiers in Fungal Biology,2022,Candida albicans,Fks1,Caspofungin,F641del,4.0,Not determined,MH128 (4N),Evolved,Looked at FKS1 as candidate gene; MIC values potentially available in mat sup,F639del
448,Ksiezopolska,Current Biology,2021,Candida glabrata,Fks1,Anidulafungin,S629P,4.0,8 μg/mL,TGL00081,Evolved,microbroth dilution,S643P
486,Ksiezopolska,Current Biology,2021,Candida glabrata,Fks1,Anidulafungin,S629P,4.0,4 μg/mL,TGL00257,Evolved,microbroth dilution,S643P
487,Ksiezopolska,Current Biology,2021,Candida glabrata,Fks1,Anidulafungin,S629P,4.0,4 μg/mL,TGL00258,Evolved,microbroth dilution,S643P
721,Avramovska,Frontiers in Fungal Biology,2022,Candida albicans,Fks1,Caspofungin,F641C,4.0,2.5 μg/mL,MH84 (2N),Evolved,both sequenced isolates from two of three sequenced evolved initially-diploid populations were homozygous,F639C
725,Avramovska,Frontiers in Fungal Biology,2022,Candida albicans,Fks1,Caspofungin,F641del,4.0,2.5 μg/mL,MH128 (4N),Evolved,Five of 12 sequenced tetraploid isolates (two isolates sequenced from six evolved population) had a 3 bp deletion ,F639del
781,Gardiner,Medical Mycology,2005,Aspergillus fumigatus,Fks1,Caspofungin,S678Y,1.0,4 μg/mL,FKS-S678Y,Unknown,,L642Y
836,Accoceberry,Journal of Antimicrobial Chemotherapy,2019,Candida lusitaniae,Fks1,Caspofungin,F634V,1.0,1.5 µg/mL,"F1 trp1Δ3', ura3Δ5'",Lab,"MIC medium : RPMI 1640, 2% glucose, pH buffered = 7,0, 0,165M MOPS",F639V
837,Accoceberry,Journal of Antimicrobial Chemotherapy,2019,Candida lusitaniae,Fks1,Caspofungin,S638P,1.0,>32 µg/mL,"F1 trp1Δ3', ura3Δ5'",Lab,"MIC medium : RPMI 1640, 2% glucose, pH buffered = 7,0, 0,165M MOPS",S643P
839,Accoceberry,Journal of Antimicrobial Chemotherapy,2019,Candida lusitaniae,Fks1,Caspofungin,F634del,1.0,32 µg/mL (256 fold),"F1 trp1Δ3', ura3Δ5'",Lab,"MIC medium : RPMI 1640, 2% glucose, pH buffered = 7,0, 0,165M MOPS",F639del
840,Accoceberry,Journal of Antimicrobial Chemotherapy,2019,Candida lusitaniae,Fks1,Caspofungin,P642A,1.0,0.75 µg/mL (6 fold),"F1 trp1Δ3', ura3Δ5'",Lab,"MIC medium : RPMI 1640, 2% glucose, pH buffered = 7,0, 0,165M MOPS",P647A
889,Ning,Emerging Microbes and Infections,2022,Candida parapsilosis,Fks1,Anidulafungin,S656P,1.0,>64 µg/mL,,Lab,"MIC : CLSI broth microdilution method
This mutation was originally found in a clinical isolate resistant to all of these treatments",S643P
890,Ning,Emerging Microbes and Infections,2022,Candida parapsilosis,Fks1,Caspofungin,S656P,1.0,>64 µg/mL,,Lab,"MIC : CLSI broth microdilution method
This mutation was originally found in a clinical isolate resistant to all of these treatments",S643P
891,Ning,Emerging Microbes and Infections,2022,Candida parapsilosis,Fks1,Micafungin,S656P,1.0,>64 µg/mL,,Lab,"MIC : CLSI broth microdilution method
This mutation was originally found in a clinical isolate resistant to all of these treatments",S643P
893,Ning,Emerging Microbes and Infections,2022,Candida metapsilosis,Fks1,Anidulafungin,S656P,1.0,64 fold,,Lab,"MIC : CLSI broth microdilution method
This mutation was originally found in a clinical isolate resistant to all of these treatments",S643P
894,Ning,Emerging Microbes and Infections,2022,Candida metapsilosis,Fks1,Caspofungin,S656P,1.0,64 fold,,Lab,"MIC : CLSI broth microdilution method
This mutation was originally found in a clinical isolate resistant to all of these treatments",S643P
895,Ning,Emerging Microbes and Infections,2022,Candida metapsilosis,Fks1,Micafungin,S656P,1.0,512 fold,,Lab,"MIC : CLSI broth microdilution method
This mutation was originally found in a clinical isolate resistant to all of these treatments",S643P
1118,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Caspofungin,S645P,4.0,>16 µg/mL,"SC5314, M70",Evolved,,S643P
1119,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Caspofungin,S645Y,4.0,>16 µg/mL,"SC5314, M70",Evolved,,S643Y
1120,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Caspofungin,S645F,4.0,>16 µg/mL,"SC5314, M70",Evolved,,S643F
1121,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Caspofungin,F641S,4.0,>16 µg/mL,M70,Evolved,,F639S
1122,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Caspofungin,L644F,4.0,>16 µg/mL,M70,Evolved,,L642F
1123,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Caspofungin,S645C,4.0,>16 µg/mL,M70,Evolved,,S643C
1124,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Micafungin,S645P,4.0,>1 µg/mL,"SC5314, M70",Evolved,,S643P
1125,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Micafungin,S645Y,4.0,>1 µg/mL,"SC5314, M70",Evolved,,S643Y
1126,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Micafungin,S645F,4.0,>1 µg/mL,"SC5314, M70",Evolved,,S643F
1127,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Micafungin,F641S,4.0,>16 µg/mL,M70,Evolved,,F639S
1128,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Micafungin,L644F,4.0,>16 µg/mL,M70,Evolved,,L642F
1129,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Micafungin,S645C,4.0,>16 µg/mL,M70,Evolved,,S643C
1130,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Anidulafungin,S645P,4.0,>0.5 µg/mL,"SC5314, M70",Evolved,,S643P
1131,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Anidulafungin,S645Y,4.0,>0.5 µg/mL,"SC5314, M70",Evolved,,S643Y
1132,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Anidulafungin,S645F,4.0,>0.5 µg/mL,"SC5314, M70",Evolved,,S643F
1133,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Anidulafungin,F641S,4.0,>2 µg/mL,M70,Evolved,,F639S
1134,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Anidulafungin,L644F,4.0,>2 µg/mL,M70,Evolved,,L642F
1135,Balashov,Antimicrobial Agents and Chemotherapy,2006,Candida albicans,Fks1,Anidulafungin,S645C,4.0,>2 µg/mL,M70,Evolved,,S643C
1168,Accoceberry,Journal of Antimicrobial Chemotherapy,2019,Candida lusitaniae,Fks1,Caspofungin,F634V,1.0,1.5 µg/mL,CBS 6936,Lab,,F639V
1169,Accoceberry,Journal of Antimicrobial Chemotherapy,2019,Candida lusitaniae,Fks1,Caspofungin,S638P,1.0,>32 µg/mL,CBS 6936,Lab,,S643P
1171,Accoceberry,Journal of Antimicrobial Chemotherapy,2019,Candida lusitaniae,Fks1,Caspofungin,F634del,1.0,32 µg/mL,CBS 6936,Lab,,F639del
1172,Accoceberry,Journal of Antimicrobial Chemotherapy,2019,Candida lusitaniae,Fks1,Caspofungin,P642A,1.0,0.75 µg/mL,CBS 6936,Lab,,P647A
